How many patents does
Gw Pharma have?
patents
790
families
62
granted
178
applications
612
US
139
GB
131
EP
92
WO
38
JP
35
CN
25
KR
17
RoW
313
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Gw Pharma
Top ten assignees appearing on patents
2009 - 2018
| gw pharma | 710 |
| otsuka pharmaceutical company | 282 |
| gw research | 11 |
| gw pharma limited and otsuka pharm… 🛈 | 3 |
| gw pharma limited, salisbury | 2 |
| gw pharmaceuticals | 2 |
| gw phama | 1 |
| gw pharmaceutical | 1 |
2009
| gw pharma | 49 |
| otsuka pharmaceutical company | 14 |
| gw phama | 1 |
2018
| gw pharma | 51 |
| otsuka pharmaceutical company | 8 |
| gw research | 7 |
Gw Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | 48 | 2009 |
| use of cannabinoids in the treatment of epilepsy | 38 | 2014 |
| anti-tumoural effects of cannabinoid combinations | 38 | 2008 |
| phytocannabinoids in the treatment of cancer | 38 | 2010 |
| use of cannabinoids in combination with an anti-psychotic medicament | 37 | 2008 |
| cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or … 🛈 | 36 | 2008 |
| cannabinoids for use in the treatment of neuropathic pain | 32 | 2011 |
| use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy | 31 | 2010 |
| a pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and … 🛈 | 31 | 2011 |
| use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epilep… 🛈 | 29 | 2011 |